Retour
Également cotée sous
ARGNF
OTC
Fourchette du Jour
666,79 €
677,85 €
Fourchette 52 Semaines
510,06 €
934,62 €
Volume
256 342
Moyenne 50J / 200J
791,83 €
/
749,96 €
Clôture Précédente
681,85 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 32,4 | 0,3 |
| P/B | 5,7 | 2,9 |
| ROE % | 20,2 | 3,7 |
| Net Margin % | 31,1 | 3,8 |
| Rev Growth 5Y % | 70,1 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
1 026,71 €
+51.5%
Low: 858,00 €
High: 1 317,00 €
P/E Prévisionnel
25,8
BPA Prévisionnel
26,47 €
Croissance BPA (est.)
+0,0%
CA Est.
6 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
59,47 €
51,80 € – 67,36 €
|
11 B | 5 |
| FY2029 |
51,95 €
45,25 € – 58,84 €
|
9,8 B | 11 |
| FY2028 |
45,30 €
39,46 € – 51,32 €
|
8,5 B | 9 |
Points Clés
Revenue grew 70,11% annually over 5 years — strong growth
Earnings grew 55,58% over the past year
ROE of 20,22% indicates high profitability
Net margin of 31,12% shows strong profitability
Debt/Equity of 0,01 — conservative balance sheet
Generating 844,30M in free cash flow
Croissance
Revenue Growth (5Y)
70,11%
Revenue (1Y)90,12%
Earnings (1Y)55,58%
FCF Growth (3Y)N/A
Qualité
Return on Equity
20,22%
ROIC9,85%
Net Margin31,12%
Op. Margin23,35%
Sécurité
Debt / Equity
0,01
Current Ratio5,23
Interest Coverage237,50
Valorisation
P/E Ratio
32,35
P/B Ratio5,73
EV/EBITDA39,61
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 90,12% | Revenue Growth (3Y) | 84,27% |
| Earnings Growth (1Y) | 55,58% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 70,11% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,16B | Net Income (TTM) | 1,30B |
| ROE | 20,22% | ROA | 14,93% |
| Gross Margin | 89,14% | Operating Margin | 23,35% |
| Net Margin | 31,12% | Free Cash Flow (TTM) | 844,30M |
| ROIC | 9,85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 5,23 |
| Interest Coverage | 237,50 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 32,35 | P/B Ratio | 5,73 |
| P/S Ratio | 10,07 | PEG Ratio | 0,77 |
| EV/EBITDA | 39,61 | Dividend Yield | 0,00% |
| Market Cap | 41,93B | Enterprise Value | 38,52B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,16B | 2,19B | 1,23B | 410,75M | 497,28M |
| Net Income | 1,30B | 833,04M | -295,05M | -709,59M | -407,63M |
| EPS (Diluted) | 19,63 | 12,78 | -5,16 | -13,05 | -7,99 |
| Gross Profit | 3,71B | 1,96B | 1,11B | 381,32M | 497,28M |
| Operating Income | 972,46M | -21,65M | -425,05M | -720,34M | -348,75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8,68B | 6,20B | 4,54B | 3,13B | 2,85B |
| Total Liabilities | 1,36B | 704,24M | 444,95M | 320,56M | 316,05M |
| Shareholders' Equity | 7,32B | 5,50B | 4,10B | 2,81B | 2,53B |
| Total Debt | 83,49M | 39,05M | 20,00M | 12,43M | 11,47M |
| Cash & Equivalents | 3,49B | 1,50B | 2,05B | 800,74M | 1,33B |
| Current Assets | 6,90B | 4,88B | 4,12B | 2,77B | 2,54B |
| Current Liabilities | 1,32B | 669,92M | 422,99M | 302,28M | 301,24M |
Scores de Stratégies
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Activité Récente
Entré
Growth Investing (Philip Fisher)
Mar 24, 2026
Entré
Full Throttle
Mar 24, 2026
Entré
Lower Risk
Mar 24, 2026